BSE - Delayed Quote INR

Jubilant Pharmova Limited (JUBLPHARMA.BO)

908.15
+28.25
+(3.21%)
At close: 3:29:59 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 18.22B
Earnings 1.15B

Q4'22

Q2'24

Q3'24

Q4'24

0
5B
10B
15B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,235.00
1,310.00 Average
908.15 Current
1,385.00 High

Earnings Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts 1--22
Avg. Estimate 8.5041.7533.8
Low Estimate 8.5031.933
High Estimate 8.5051.634.6
Year Ago EPS ------41.75

Revenue Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts 2--22
Avg. Estimate 19.24B--72.3B79.06B
Low Estimate 19.16B--72.27B78.13B
High Estimate 19.32B--72.33B79.98B
Year Ago Sales ------72.3B
Sales Growth (year/est) ------9.35%

Earnings History

Currency in INR 6/30/2024 9/30/2024
EPS Est. 44.24.9
EPS Actual 6.327.14
Difference -37.882.24
Surprise % -85.70%45.80%

EPS Trend

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 8.5041.7533.8
7 Days Ago 0041.7533.8
30 Days Ago 0041.7533.8
60 Days Ago 0038.432.5
90 Days Ago 0038.432.5

EPS Revisions

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days ------1
Down Last 30 Days ------1

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
JUBLPHARMA.BO -------19.04%
S&P 500 13.21%3.06%8.01%13.77%

Related Tickers